SmarterDx

Who owns SmarterDx now?

Michael Gao, MD, and Joshua Geleris, MD, founded SmarterDx in New York in 2020. It raised a $50M Series B led by Transformation Capital in May 2024, about $71M in total (Pulse 2.0).

In April 2025 New Mountain Capital combined it with Thoughtful.ai and Access Healthcare as Smarter Technologies. Fierce Healthcare reported Jeremy Delinsky as CEO and more than $800M in expected revenue. The product pages at smarterdx.com still carry the SmarterDx name and its module names.

What does it do?

The vendor describes a "clinically intelligent RCM platform" that "surfaces opportunities your teams can validate and defend." The modules:

• SmarterPrebill reads notes, labs, vitals, orders, imaging and codes before billing.
• SmarterUtilization handles prior authorization and level-of-care review.
• SmarterNotes drafts notes with revenue-cycle awareness.
• SmarterCharges covers charge capture, and SmarterDenials writes appeal letters.

Altair Health, a competitor, says on its comparison page (altair-health.com/docs/compare/smarterdx) that SmarterDx drafts appeals but has no prior-authorization product and no per-payer learning. The SmarterDx product pages list prior authorization under SmarterUtilization, so the two accounts differ.

What does SmarterDx claim about results?

The vendor reports 85+ health systems, 300+ hospital sites and 21M+ validated encounters. It cites "$4.5M average realized annual revenue per 10,000 DRG discharges" and a 5:1 return. Its case studies describe $1.5M recovered from a denials backlog, a 91% appeal win rate at an academic system and $11.3M in annual net new revenue. An ROI calculator is also on the site.

AIChief lists a hospital focus and results that depend on record quality as drawbacks.

What about EHRs, security and regulation?

SmarterDx says it works with "all major EHRs" and shows logos rather than a named list. Its platform page states SOC 2 Type II, HIPAA, AWS and TX-RAMP, without a report date. HITRUST is not stated. SmarterDx is not an FDA-regulated device.

What does it cost?

SmarterDx publishes no price. The ROI calculator on the site is the only number-based tool it offers a prospect.

The verdict

For a hospital with a documented denials or under-coding problem, SmarterDx belongs on the shortlist, and the case studies describe that profile. A buyer who wants a standalone startup vendor should know the product now sits inside Smarter Technologies, a larger company than the one that built it. A small practice, or a physician who wants a documentation scribe, has no use for it, and a buyer who needs independent proof of the 5:1 return has only the vendor's figures to go on.